How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/infection-caused-by-helicobacter-pylori.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Infection caused by Helicobacter pylori — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Infection caused by Helicobacter pylori (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Infection caused by Helicobacter pylori, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Biaxin	clarithromycin	Generic (originally Abbott/AbbVie)	Macrolide Antimicrobial [EPC]	Potassium voltage-gated channel subfamily H member 2	1991-10-31
Amoxil	amoxicillin	Generic (originally Beecham/GSK)	Aminopenicillin (Beta-lactam antibiotic)	5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 2C	1972-01-01
Amoxycillin	Amoxycillin	King George's Medical University		5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 2C
Amoxicilli	Amoxicilli	Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.		5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 2C
Takecab	Takecab	Genuine Research Center, Egypt		Potassium-transporting ATPase

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Generic (originally Abbott/AbbVie) · 1 drug in Infection caused by Helicobacter pylori
Generic (originally Beecham/GSK) · 1 drug in Infection caused by Helicobacter pylori
Genuine Research Center, Egypt · 1 drug in Infection caused by Helicobacter pylori
King George's Medical University · 1 drug in Infection caused by Helicobacter pylori
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. · 1 drug in Infection caused by Helicobacter pylori

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Infection caused by Helicobacter pylori:

Cite this brief

Drug Landscape (2026). Infection caused by Helicobacter pylori — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/infection-caused-by-helicobacter-pylori. Accessed 2026-06-10.

Infection caused by Helicobacter pylori full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing